Establishment Labs Holdings, Inc. (ESTA)
72.51
-0.21
(-0.29%)
USD |
NASDAQ |
Dec 12, 16:00
72.53
+0.02
(+0.03%)
Pre-Market: 20:00
Establishment Labs Holdings EPS Diluted (Quarterly): -0.3763 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Medpace Holdings, Inc. | 3.857 |
| The Oncology Institute, Inc. | -0.1413 |
| CEL-SCI Corp. | -1.365 |
| AIM ImmunoTech, Inc. | -1.569 |
| IGC Pharma, Inc. | -0.0201 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.15M |
| Revenue (Quarterly) | 53.78M |
| Total Expenses (Quarterly) | 64.93M |
| Enterprise Value | 2.298B |
| Gross Profit Margin (Quarterly) | 70.09% |
| Profit Margin (Quarterly) | -20.72% |
| Earnings Yield | -3.92% |
| Normalized Earnings Yield | -3.925 |